nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP1—chronic obstructive pulmonary disease	0.682	1	CbGaD
Doxycycline—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0231	0.282	CbGbCtD
Doxycycline—MMP13—leg—chronic obstructive pulmonary disease	0.0188	0.248	CbGeAlD
Doxycycline—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0156	0.19	CbGbCtD
Doxycycline—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0149	0.182	CbGbCtD
Doxycycline—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0133	0.162	CbGbCtD
Doxycycline—MMP1—leg—chronic obstructive pulmonary disease	0.0132	0.175	CbGeAlD
Doxycycline—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00779	0.0949	CbGbCtD
Doxycycline—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00736	0.0896	CbGbCtD
Doxycycline—MMP13—respiratory system—chronic obstructive pulmonary disease	0.00467	0.0617	CbGeAlD
Doxycycline—MMP8—respiratory system—chronic obstructive pulmonary disease	0.00421	0.0557	CbGeAlD
Doxycycline—MMP13—connective tissue—chronic obstructive pulmonary disease	0.00411	0.0543	CbGeAlD
Doxycycline—MMP7—respiratory system—chronic obstructive pulmonary disease	0.00372	0.0492	CbGeAlD
Doxycycline—MMP8—connective tissue—chronic obstructive pulmonary disease	0.00371	0.049	CbGeAlD
Doxycycline—MMP1—respiratory system—chronic obstructive pulmonary disease	0.00328	0.0434	CbGeAlD
Doxycycline—MMP7—connective tissue—chronic obstructive pulmonary disease	0.00328	0.0433	CbGeAlD
Doxycycline—MMP1—connective tissue—chronic obstructive pulmonary disease	0.00289	0.0382	CbGeAlD
Doxycycline—MMP1—bronchus—chronic obstructive pulmonary disease	0.0027	0.0357	CbGeAlD
Doxycycline—MMP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00265	0.0349	CbGeAlD
Doxycycline—MMP13—lung—chronic obstructive pulmonary disease	0.00248	0.0328	CbGeAlD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP12—chronic obstructive pulmonary disease	0.00229	0.0146	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP12—chronic obstructive pulmonary disease	0.00226	0.0145	CbGpPWpGaD
Doxycycline—MMP8—lung—chronic obstructive pulmonary disease	0.00224	0.0296	CbGeAlD
Doxycycline—MMP8—Collagen degradation—MMP14—chronic obstructive pulmonary disease	0.00205	0.0131	CbGpPWpGaD
Doxycycline—MMP7—lung—chronic obstructive pulmonary disease	0.00198	0.0261	CbGeAlD
Doxycycline—MMP1—Collagen degradation—MMP12—chronic obstructive pulmonary disease	0.00189	0.0121	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.00181	0.0116	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.00175	0.0112	CbGpPWpGaD
Doxycycline—MMP1—lung—chronic obstructive pulmonary disease	0.00174	0.023	CbGeAlD
Doxycycline—MMP13—Degradation of the extracellular matrix—ELANE—chronic obstructive pulmonary disease	0.00174	0.0111	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.00172	0.011	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP12—chronic obstructive pulmonary disease	0.0017	0.0109	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—ELANE—chronic obstructive pulmonary disease	0.00168	0.0107	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.00166	0.0106	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP14—chronic obstructive pulmonary disease	0.0015	0.00956	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP14—chronic obstructive pulmonary disease	0.00145	0.00924	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.0014	0.00892	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—ELANE—chronic obstructive pulmonary disease	0.00135	0.00859	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP14—chronic obstructive pulmonary disease	0.00133	0.00847	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP12—chronic obstructive pulmonary disease	0.00124	0.00792	CbGpPWpGaD
Doxycycline—Minocycline—IL1B—chronic obstructive pulmonary disease	0.00123	0.312	CrCbGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP12—chronic obstructive pulmonary disease	0.0012	0.00765	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.00117	0.00746	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP14—chronic obstructive pulmonary disease	0.00116	0.00738	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.00111	0.00709	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP14—chronic obstructive pulmonary disease	0.00104	0.00664	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.001	0.00639	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP1—chronic obstructive pulmonary disease	0.000968	0.00618	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP14—chronic obstructive pulmonary disease	0.000963	0.00615	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP12—chronic obstructive pulmonary disease	0.000958	0.00612	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP14—chronic obstructive pulmonary disease	0.00093	0.00594	CbGpPWpGaD
Doxycycline—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000922	0.00589	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—chronic obstructive pulmonary disease	0.000912	0.00582	CbGpPWpGaD
Doxycycline—Minocycline—VEGFA—chronic obstructive pulmonary disease	0.000896	0.228	CrCbGaD
Doxycycline—Minocycline—MMP9—chronic obstructive pulmonary disease	0.000866	0.22	CrCbGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.000853	0.00544	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.000824	0.00526	CbGpPWpGaD
Doxycycline—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000815	0.00521	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.00081	0.00517	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB2—chronic obstructive pulmonary disease	0.000805	0.00514	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP1—chronic obstructive pulmonary disease	0.000782	0.00499	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—chronic obstructive pulmonary disease	0.000779	0.00497	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP14—chronic obstructive pulmonary disease	0.000758	0.00484	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP14—chronic obstructive pulmonary disease	0.000732	0.00468	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.00073	0.00466	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.000713	0.00455	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.000713	0.00455	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP1—chronic obstructive pulmonary disease	0.000706	0.00451	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.000705	0.0045	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—HMOX1—chronic obstructive pulmonary disease	0.000703	0.00449	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MMP12—chronic obstructive pulmonary disease	0.000699	0.00446	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP1—chronic obstructive pulmonary disease	0.000682	0.00435	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP1—chronic obstructive pulmonary disease	0.000682	0.00435	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.00068	0.00434	CbGpPWpGaD
Doxycycline—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000667	0.00426	CbGpPWpGaD
Doxycycline—Methacycline—ALB—chronic obstructive pulmonary disease	0.000659	0.167	CrCbGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000646	0.00412	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—chronic obstructive pulmonary disease	0.00064	0.00408	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP14—chronic obstructive pulmonary disease	0.000586	0.00374	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000569	0.00363	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.000564	0.0036	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—chronic obstructive pulmonary disease	0.000563	0.00359	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	0.000554	0.00354	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—chronic obstructive pulmonary disease	0.000546	0.00349	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—chronic obstructive pulmonary disease	0.000523	0.00334	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.00052	0.00332	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.00052	0.00332	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.000502	0.00321	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.000502	0.00321	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000496	0.00317	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—chronic obstructive pulmonary disease	0.000495	0.00316	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP1—chronic obstructive pulmonary disease	0.00049	0.00313	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000479	0.00306	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000471	0.00301	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MMP1—chronic obstructive pulmonary disease	0.000459	0.00293	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	0.000457	0.00292	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—PLAU—chronic obstructive pulmonary disease	0.000457	0.00291	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000455	0.0029	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.000436	0.00278	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—EDN1—chronic obstructive pulmonary disease	0.000433	0.00276	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CXCL8—chronic obstructive pulmonary disease	0.000412	0.00263	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—chronic obstructive pulmonary disease	0.000411	0.00262	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	0.000409	0.00261	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—chronic obstructive pulmonary disease	0.000404	0.00258	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.000402	0.00256	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.000402	0.00256	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000398	0.00254	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—chronic obstructive pulmonary disease	0.000397	0.00253	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.000397	0.00253	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	0.000395	0.00252	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000393	0.00251	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000383	0.00244	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—chronic obstructive pulmonary disease	0.000382	0.00244	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—chronic obstructive pulmonary disease	0.000379	0.00242	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—chronic obstructive pulmonary disease	0.000369	0.00235	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—chronic obstructive pulmonary disease	0.000364	0.00232	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—chronic obstructive pulmonary disease	0.000358	0.00229	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP1—chronic obstructive pulmonary disease	0.000357	0.00228	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.000355	0.00227	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000349	0.00223	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP1—chronic obstructive pulmonary disease	0.000345	0.0022	CbGpPWpGaD
Doxycycline—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000339	0.00216	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—chronic obstructive pulmonary disease	0.000335	0.00214	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	0.000329	0.0021	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000328	0.00209	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—TGFB1—chronic obstructive pulmonary disease	0.000327	0.00209	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—chronic obstructive pulmonary disease	0.000324	0.00207	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—chronic obstructive pulmonary disease	0.000319	0.00204	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.000318	0.00203	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	0.000318	0.00203	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.000317	0.00202	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—chronic obstructive pulmonary disease	0.000317	0.00202	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—chronic obstructive pulmonary disease	0.000312	0.00199	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—chronic obstructive pulmonary disease	0.000309	0.00197	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.000307	0.00196	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—chronic obstructive pulmonary disease	0.000306	0.00195	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—PLAU—chronic obstructive pulmonary disease	0.000304	0.00194	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—chronic obstructive pulmonary disease	0.000301	0.00192	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—chronic obstructive pulmonary disease	0.000295	0.00188	CbGpPWpGaD
Doxycycline—Tetracycline—ALB—chronic obstructive pulmonary disease	0.000289	0.0733	CrCbGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000285	0.00182	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000273	0.00174	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—chronic obstructive pulmonary disease	0.000271	0.00173	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000269	0.00172	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—chronic obstructive pulmonary disease	0.000266	0.0017	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.000264	0.00169	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—TGFB1—chronic obstructive pulmonary disease	0.000261	0.00167	CbGpPWpGaD
Doxycycline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000259	0.00166	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.000259	0.00165	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.000255	0.00163	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—chronic obstructive pulmonary disease	0.000253	0.00162	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.00025	0.0016	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.000245	0.00157	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—chronic obstructive pulmonary disease	0.000243	0.00155	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—chronic obstructive pulmonary disease	0.00024	0.00153	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000239	0.00152	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000224	0.00143	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—chronic obstructive pulmonary disease	0.000223	0.00142	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—chronic obstructive pulmonary disease	0.000218	0.00139	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000215	0.00137	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000215	0.00137	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.000213	0.00136	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—chronic obstructive pulmonary disease	0.00021	0.00134	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000208	0.00133	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.000206	0.00132	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000205	0.00131	CbGpPWpGaD
Doxycycline—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00128	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—chronic obstructive pulmonary disease	0.000201	0.00128	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000201	0.00128	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.0002	0.00128	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0002	0.00127	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000194	0.00124	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000191	0.00122	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	0.000189	0.00121	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—chronic obstructive pulmonary disease	0.000185	0.00118	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000183	0.00117	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.000181	0.00116	CbGpPWpGaD
Doxycycline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00112	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000171	0.00109	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—chronic obstructive pulmonary disease	0.000167	0.00107	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.00016	0.00102	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.00016	0.00102	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00102	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000156	0.000995	CbGpPWpGaD
Doxycycline—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.000972	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000152	0.000972	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.00015	0.000956	CbGpPWpGaD
Doxycycline—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.000933	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000145	0.000923	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000143	0.00091	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.000898	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.00014	0.000894	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000137	0.000875	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.000132	0.000842	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000127	0.000811	CbGpPWpGaD
Doxycycline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.000811	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—chronic obstructive pulmonary disease	0.000122	0.00078	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000122	0.000778	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000121	0.000771	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000119	0.000762	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000119	0.000759	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	0.000116	0.000742	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.000738	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000114	0.000726	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.00011	0.000701	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000107	0.000681	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	0.000106	0.000679	CbGpPWpGaD
Doxycycline—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.000678	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.000652	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	9.84e-05	0.000628	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	9.65e-05	0.000616	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	9.61e-05	0.000614	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	9.56e-05	0.00061	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.44e-05	0.000603	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	8.78e-05	0.00056	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	8.71e-05	0.000556	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.49e-05	0.000542	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	8.42e-05	0.000537	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	8.41e-05	0.000537	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—chronic obstructive pulmonary disease	7.94e-05	0.000507	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	7.56e-05	0.000483	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.000479	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	7.18e-05	0.000458	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.13e-05	0.000455	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	6.93e-05	0.000442	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAU—chronic obstructive pulmonary disease	6.74e-05	0.00043	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	6.72e-05	0.000429	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	6.21e-05	0.000396	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS2—chronic obstructive pulmonary disease	6.19e-05	0.000395	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	6.07e-05	0.000388	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.99e-05	0.000382	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	5.54e-05	0.000354	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.000348	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	5.23e-05	0.000334	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	5.22e-05	0.000333	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ALB—chronic obstructive pulmonary disease	5.21e-05	0.000332	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.19e-05	0.000332	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.98e-05	0.000318	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.92e-05	0.000314	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.41e-05	0.000282	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.4e-05	0.000281	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.000278	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.96e-05	0.000253	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.59e-05	0.000229	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.58e-05	0.000228	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.47e-05	0.000222	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.35e-05	0.000214	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.31e-05	0.000211	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.29e-05	0.00021	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.15e-05	0.000201	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.11e-05	0.000198	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.8e-05	0.000179	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—chronic obstructive pulmonary disease	2.71e-05	0.000173	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.64e-05	0.000168	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.000167	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.58e-05	0.000165	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.18e-05	0.000139	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.15e-05	0.000137	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.01e-05	0.000128	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2e-05	0.000128	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.98e-05	0.000126	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000121	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.00012	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000107	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.53e-05	9.75e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.01e-05	6.46e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.85e-06	6.29e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.15e-06	5.84e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.38e-06	3.43e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.32e-06	3.39e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.85e-06	3.1e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.47e-06	2.85e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.73e-06	2.38e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.68e-06	2.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.43e-06	2.19e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.25e-06	2.07e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.21e-06	1.41e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.11e-06	1.35e-05	CbGpPWpGaD
